Cahaba Updates Self-Administered Drug (SAD) List
The drugs listed below are being added to the Cahaba GBA ‘Self-Administered Drug (SAD) List’.
|Generic Name||HCPCS Code||Comments|
|Fuzeon®||Injection, enfuvirtide, 1 mg||J1324||Rationale: SC injection administered by patient twice daily for a chronic condition.|
|Increlex®, Iplex™||Injection, mecasermin, 1 mg||J2170||Rationale: SC injection administered by patient daily/twice daily for a long-term condition.|
|Muse®||Alprostadil urethral suppository||J0275||Rationale: Apparent on its face. Urethral suppository administered by patient on an as needed basis.|
|Somavert®||Pegvisomant for injection Use||J3490||Rationale: SC injection administered by patient daily for a chronic condition.|
Notice of Non-Coverage for this update: April 15, 2010
Effective Date of Non-Coverage for this update: June 1, 2010
The ‘Self-Administered Drug (SAD) List’ article can be accessed from the Cahaba GBA website at the Local Coverage Determinations (LCDs) and Articles page of Cahaba’s website (choose the ‘SAD List’ for your state).
Updates on coverage and other topics of interest to hospitals can be viewed on the Part A What’s New page of the Cahaba GBA website.